SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation

OBJECTIVES: Humoral and cellular immunity to SARS‐CoV‐2 following COVID‐19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS‐CoV‐2 amidst the ongoing pandemic. METHODS: Here,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Immunology
Main Authors: Sandberg, John Tyler, Varnaitė, Renata, Christ, Wanda, Chen, Puran, Muvva, Jagadeeswara R, Maleki, Kimia T, García, Marina, Dzidic, Majda, Folkesson, Elin, Skagerberg, Magdalena, Ahlén, Gustaf, Frelin, Lars, Sällberg, Matti, Eriksson, Lars I, Rooyackers, Olav, Sönnerborg, Anders, Buggert, Marcus, Björkström, Niklas K, Aleman, Soo, Strålin, Kristoffer, Klingström, Jonas, Ljunggren, Hans‐Gustaf, Blom, Kim, Gredmark‐Russ, Sara
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256672/
https://ncbi.nlm.nih.gov/pubmed/34257967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1306
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados